AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From CBS Marketwatch (Stories))
Byline: Larry King
BOSTON (MarketWatch) -- Clinical researchers have found more evidence linking use of the Johnson & Johnson cardiac drug Natrecor and impaired kidney function, according to a leading medical publication.
But a spokeswoman for Scios Inc., the J&J subsidiary that markets and manufactures the drug, said Monday there is no new information in the study, and said the authors were warned in advance of publication they were using inaccurately high dosage levels to draw their conclusions.
In the March 21 edition of the American Heart Association's journal "Circulation," a group of researchers…